Trial intelligence / Profile preview

Tranexamic Acid in Foot and Ankle Surgeries

NCT03653429Phase 4Completed

Sponsor
Icahn School of Medicine at Mount Sinai
Start
Mar 2018
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in hallux valgus and Foot fracture comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Total Estimated Blood Loss. Started Mar 2018; status: completed.

02

Drugs

tranexamic acid
03

Conditions

hallux valgusFoot fracture

Beyond the preview

Go deeper on NCT03653429.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03653429.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call